Protagonist Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.6M | 289k | 22.93 |
| 2023-09-30 | $1.2M | 71k | 16.68 |
| 2023-06-30 | $1.5M | 65k | 23.00 |
| 2023-03-31 | $1.5M | 65k | 23.00 |
| 2022-09-30 | $230k | 27k | 8.43 |
| 2022-06-30 | $258k | 33k | 7.91 |
| 2022-03-31 | $774k | 33k | 23.68 |
| 2021-12-31 | $1.1M | 33k | 34.20 |
| 2021-09-30 | $489k | 28k | 17.72 |
| 2021-06-30 | $1.2M | 28k | 44.88 |
| 2021-03-31 | $648k | 25k | 25.90 |
| 2020-12-31 | $246k | 12k | 20.16 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas